185 related articles for article (PubMed ID: 29491471)
21. Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease.
Carbonetto P; Stephens M
PLoS Genet; 2013; 9(10):e1003770. PubMed ID: 24098138
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes.
Zhernakova A; Alizadeh BZ; Eerligh P; Hanifi-Moghaddam P; Schloot NC; Diosdado B; Wijmenga C; Roep BO; Koeleman BP
Genes Immun; 2006 Oct; 7(7):544-9. PubMed ID: 16855620
[TBL] [Abstract][Full Text] [Related]
24. T Cell Receptor Genotype and
Mordes JP; Cort L; Liu Z; Eberwine R; Blankenhorn EP; Pierce BG
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205929
[TBL] [Abstract][Full Text] [Related]
25. Autoimmunity risk- and protection-associated IL7RA genetic variants differentially affect soluble and membrane IL-7Rα expression.
Lundtoft C; Seyfarth J; Oberstrass S; Rosenbauer J; Baechle C; Roden M; Holl RW; Mayatepek E; Kummer S; Meissner T; Jacobsen M
J Autoimmun; 2019 Feb; 97():40-47. PubMed ID: 30342817
[TBL] [Abstract][Full Text] [Related]
26. Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes.
Newman JRB; Conesa A; Mika M; New FN; Onengut-Gumuscu S; Atkinson MA; Rich SS; McIntyre LM; Concannon P
Genome Res; 2017 Nov; 27(11):1807-1815. PubMed ID: 29025893
[TBL] [Abstract][Full Text] [Related]
27. RNASEH1 gene variants are associated with autoimmune type 1 diabetes in Colombia.
Pineda-Trujillo N; Rodríguez-Acevedo A; Rodríguez A; Ruíz-Linares A; Bedoya G; Rivera A; Alfaro JM
J Endocrinol Invest; 2018 Jul; 41(7):755-764. PubMed ID: 29204916
[TBL] [Abstract][Full Text] [Related]
28. Polymorphic variation in the CBLB gene in human type 1 diabetes.
Kosoy R; Yokoi N; Seino S; Concannon P
Genes Immun; 2004 May; 5(3):232-5. PubMed ID: 14961073
[TBL] [Abstract][Full Text] [Related]
29. The T1D-associated lncRNA
Gonzalez-Moro I; Olazagoitia-Garmendia A; Colli ML; Cobo-Vuilleumier N; Postler TS; Marselli L; Marchetti P; Ghosh S; Gauthier BR; Eizirik DL; Castellanos-Rubio A; Santin I
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9022-9031. PubMed ID: 32284404
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
Kumar N; Kaur G; Tandon N; Mehra N
Hum Immunol; 2012 May; 73(5):566-73. PubMed ID: 22366579
[TBL] [Abstract][Full Text] [Related]
31. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.
Dendrou CA; Plagnol V; Fung E; Yang JH; Downes K; Cooper JD; Nutland S; Coleman G; Himsworth M; Hardy M; Burren O; Healy B; Walker NM; Koch K; Ouwehand WH; Bradley JR; Wareham NJ; Todd JA; Wicker LS
Nat Genet; 2009 Sep; 41(9):1011-5. PubMed ID: 19701192
[TBL] [Abstract][Full Text] [Related]
32. Study of polymorphisms in 4q27, 10p15, and 22q13 regions in autoantibodies stratified type 1 diabetes patients.
Espino-Paisán L; De La Calle H; Fernández-Arquero M; Figueredo MA; De La Concha EG; Urcelay E; Santiago JL
Autoimmunity; 2011 Dec; 44(8):624-30. PubMed ID: 21875375
[TBL] [Abstract][Full Text] [Related]
33. Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells.
Hu X; Kim H; Raj T; Brennan PJ; Trynka G; Teslovich N; Slowikowski K; Chen WM; Onengut S; Baecher-Allan C; De Jager PL; Rich SS; Stranger BE; Brenner MB; Raychaudhuri S
PLoS Genet; 2014 Jun; 10(6):e1004404. PubMed ID: 24968232
[TBL] [Abstract][Full Text] [Related]
34. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Robertson CC; Inshaw JRJ; Onengut-Gumuscu S; Chen WM; Santa Cruz DF; Yang H; Cutler AJ; Crouch DJM; Farber E; Bridges SL; Edberg JC; Kimberly RP; Buckner JH; Deloukas P; Divers J; Dabelea D; Lawrence JM; Marcovina S; Shah AS; Greenbaum CJ; Atkinson MA; Gregersen PK; Oksenberg JR; Pociot F; Rewers MJ; Steck AK; Dunger DB; ; Wicker LS; Concannon P; Todd JA; Rich SS
Nat Genet; 2021 Jul; 53(7):962-971. PubMed ID: 34127860
[TBL] [Abstract][Full Text] [Related]
35. Polymorphic variant at the IL2 region is associated with type 1 diabetes and may affect serum levels of interleukin-2.
Fichna M; Zurawek M; Fichna P; Ziółkowska-Suchanek I; Januszkiewicz D; Nowak J
Mol Biol Rep; 2013 Dec; 40(12):6957-63. PubMed ID: 24154763
[TBL] [Abstract][Full Text] [Related]
36. Genome-Wide Identification of
Chen Y; Shen M; Ji C; Huang Y; Shi Y; Ji L; Qin Y; Gu Y; Fu Q; Chen H; Xu K; Yang T
Front Endocrinol (Lausanne); 2022; 13():913345. PubMed ID: 35784577
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
BMC Med Genet; 2006 Jun; 7():54. PubMed ID: 16796743
[TBL] [Abstract][Full Text] [Related]
38. Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes.
Kosoy R; Concannon P
Genes Immun; 2005 May; 6(3):231-5. PubMed ID: 15729364
[TBL] [Abstract][Full Text] [Related]
39. Linkage disequilibrium with predisposing DR3 haplotypes accounts for apparent effects of tumor necrosis factor and lymphotoxin-alpha polymorphisms on type 1 diabetes susceptibility.
Noble JA; Valdes AM; Lane JA; Green AE; Erlich HA
Hum Immunol; 2006 Dec; 67(12):999-1004. PubMed ID: 17174749
[TBL] [Abstract][Full Text] [Related]
40. Association between cytokine genes polymorphisms and type 1 diabetes: a case-control study on Saudi population.
Allam G; Nasr A; Talaat IM; Abuelsaad ASA; Bakheit AM; Nemenqani D; Alsulaimani AA
Immunol Invest; 2018 Apr; 47(3):229-240. PubMed ID: 29257900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
